Department of Pathology, Max Super Speciality Hospital, Saket, New Delhi, India.
Department of Urology, PGIMER, Chandigarh, India.
J Cancer Res Ther. 2022 Jul-Sep;18(4):1129-1136. doi: 10.4103/jcrt.JCRT_842_20.
Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma in Indian population and is divided into the prognostically important subtypes, germinal center B-cell (GCB) and activated B-cell-like (ABC), using immunohistochemistry-based algorithm.
The present study aims to evaluate the influence of immunohistochemical derived DLBCL subtype, GCB or ABC on prognostically significant variables - extranodal involvement and serum lactate dehydrogenase (LDH) level at presentation, and response to chemotherapy assessed on pre- and posttreatment fluorodeoxyglucose-positron emission tomography study.
This was a retro-prospective, 2-year observational study at a tertiary health-care center, New Delhi.
The study population includes a total 236 cases of DLBCL. According to the Hans algorithm, DLBCL cases were allocated to the GCB and ABC subgroups.
For comparison of mean values, independent t-test and analysis of variance were used. For this purpose, we used SPSS 20.0 software. P < 0.05 was considered as statistically significant.
Ninety-eight patients (41.5%) had GCB immunophenotype and 138 patients (58.5%) were ABC. A significant difference was observed between mean baseline level of LDH between GCB and ABC subtypes (P < 0.05). The proportion of cases with extranodal involvement was comparatively higher in ABC subtype (P < 0.05). Association between response to chemotherapy with DLBCL immunophenotypes was found to be highly significant (P < 0.00). The response rates were much better in GCB subtype.
The mean baseline level of LDH is significantly higher in ABC subtype. The proportion of cases with extranodal involvement was comparatively higher in ABC and shows poor response to chemotherapy as compared to GCB. Baseline LDH level was found to be important prognostic marker in the DLBCL.
弥漫性大 B 细胞淋巴瘤(DLBCL)是印度人群中最常见的非霍奇金淋巴瘤类型,使用基于免疫组织化学的算法分为预后重要的亚型,生发中心 B 细胞(GCB)和激活 B 细胞样(ABC)。
本研究旨在评估免疫组织化学衍生的 DLBCL 亚型、GCB 或 ABC 对预后有重要意义的变量的影响——初诊时的结外累及和血清乳酸脱氢酶(LDH)水平,以及通过治疗前后氟脱氧葡萄糖正电子发射断层扫描研究评估的化疗反应。
这是在新德里的一家三级保健中心进行的回顾性、为期 2 年的观察性研究。
研究人群包括总共 236 例 DLBCL 患者。根据 Hans 算法,将 DLBCL 病例分配到 GCB 和 ABC 亚组。
为了比较平均值,使用了独立 t 检验和方差分析。为此,我们使用了 SPSS 20.0 软件。P<0.05 被认为具有统计学意义。
98 例患者(41.5%)具有 GCB 免疫表型,138 例患者(58.5%)为 ABC。在 GCB 和 ABC 亚型之间,观察到 LDH 基线水平之间存在显著差异(P<0.05)。ABC 亚型中结外累及的病例比例较高(P<0.05)。与 DLBCL 免疫表型的化疗反应之间存在显著关联(P<0.00)。GCB 亚型的反应率要好得多。
ABC 亚型的 LDH 基线水平显著较高。ABC 中结外累及的病例比例较高,与 GCB 相比,对化疗反应较差。LDH 基线水平被发现是 DLBCL 的重要预后标志物。